cardiac-surgery-heart-congress-2019-keynote

4 / 4

alliedacademies
Page 9
Current Trends in Cardiology | Volume: 03
10th WORLD HEART CONGRESS
&
6 th International Congress on
CARDIOLOGY AND CARDIAC SURGERY
December 02-03, Dubai, UAE
Joint event on
Curr Trend Cardiol, Volume: 03
Notes:
Aims and Objectives: This is a prospective, interventional,
non-randomized, single group assignment, diagnostic
sub study with intention to treat. This sub study aims
to compare the diagnostic yield, or ability to detect
arrhythmias - especially paroxysmal atrial fibrillation (PAF)
- of the conventional Ambulatory Holter monitoring device
with the Wellysis S Patch, a novel, dual-lead, low-profile
device.
Background: It is widely recognized that technology can
improve the health of populations in countries around
the world. Smartphone technology is at the forefront of
innovation in low, middle and high-income countries. The
Smartphone technology has already improved the doctor-
patient interaction, reducing costs and improving care for
patients.
Methods: Patients referred for ambulatory
electrocardiographic (ECG) monitoring wore both devices
simultaneously for 24-48 hours and the incidence of
clinically significant arrhythmias were compared. Patients
who satisfied the eligibility criteria as well as referred for
ambulatory ECG monitoring were consented and enrolled
prospectively to have the Holter monitor and the Wellysis
S Patch device placed simultaneously. A patient satisfaction
survey was given to the patient and parent/guardian
after completion of the study to compare the comfort,
interferencewithdailyactivities,adverseevents(suchasskin
irritation or if either device fell off), and preference for each
device. The overall performance (comfort of wearing, ease
of use, efficiency and durability, clarity of recorded signals)
Results : When it comes to comfort of wearing, ease of
use, efficiency and durability, clarity of recorded signals of
Wellysis S Patch was found to be superior to conventional
Holter (feedback from patients, paramedical staff,
clinical staff regarding the comfort of wearing, usability,
operational efficiency) by Mc Nemars analysis, which
revealed odds ratio of 8.75 with a 95% CI 4.205 to 21.060,
P < 0.0001.
Conclusion : Multi lead ambulatory Holter monitoring
remains the gold standard for arrhythmia detection in
stroke patients. However Wellysis S Patch device has a
definite complementary role in the detection of paroxysmal
atrial fibrillation (PAF) in stroke patients. However with
advances in technology a paradigm shift is possible.
Biography
Satyanarayana Upadhyayula is a Consultant Cardiologist in Medanta
Hospital, New Delhi. He complited his MBBS from Kakatiya Medical
College in 1986. In 1990 he complited his M.D. from All India Institute
Of Medical Sciences – Biophysics, worked in Cardio Vascular Physiology,
Hemodynamics, Nuclear Medicine and Nuclear Cardiology. Fellowship in
EmergencyMedicine(FEM)July2007-June2008(RoyalCollegeofGeneral
Physicians, UK). Life Member - Indian Academy of Echocardiography.
American Heart Association (AHA) Certified Instructor in Basic Life Support
(BLS), Advanced Cardiac Life Support (ACLS) and International Trauma Life
Support (ITLS).
e:
e:
e:
Satyanarayana Upadhyayula1
Rick Hongryul Kim2, Sumit Dhingra3
1Medanta Hospital, India
2Wellysis Corporation, South Korea
3Samsung SDS, India
Wellysis S- PATCH versus Conventional HOLTER Ambulatory
Electrocardiographic Monitoring (The PACER Trial):